最新の試験


EudraCT Number: 2004-001904-10 Sponsor Protocol Number: PM0259CA301J1 Start Date: 2004-09-15
Sponsor Name: Pierre Fabre Médicament represented by IRPF
Full Title: Prospective randomised clinical phase III trial of (alternating IV and oral) vinorelbine plus cisplatin versus docetaxel plus cisplatin in first line chemotherapy of locally advanced or metastatic ...
Medical condition: Treatment in locally advanced or metastatic non-small-lung cancer.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) EE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-000329-31 Sponsor Protocol Number: EORTC 22011- 40014 Start Date: 2004-09-15
Sponsor Name: E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER
Full Title: Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III study
Medical condition: Locally Advanced Anal Cancer
Disease: Version SOC Term Classification Code Term Level
9.1 10061629 Anal neoplasm LLT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-001490-26 Sponsor Protocol Number: CRx-150-002-00 Start Date: 2004-09-15
Sponsor Name: CombinatoRx, Inc
Full Title: A SINGLE-CENTER, RANDOMIZED, SINGLE-BLIND STUDY COMPARING THE EFFECT OF CRx-150 PLUS DMARD THERAPY TO THAT OF PLACEBO PLUS DMARD THERAPY ON SERUM C-REACTIVE PROTEIN (CRP) AND CYTOKINES IN SUBJECTS ...
Medical condition: RHEUMATOID ARTHRITIS
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) EE (Completed)
Trial results: (No results available)

EudraCT Number: 2004-000139-27 Sponsor Protocol Number: A509 1018 Start Date: 2004-09-14
Sponsor Name: Pfizer AB
Full Title: A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orall...
Medical condition: Mixed dyslipidemia (Frederickson Types IIa and IIb)
Disease: Version SOC Term Classification Code Term Level
10058108
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results
EudraCT Number: 2004-004675-11 Sponsor Protocol Number: 133/2004/U Start Date: 2004-09-14
Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Full Title: Clinical trial of phase II for the a front line treatment of the non-Hodgkin lymphomas of derivation lymphocyte T Gemcitabine and Oxaliplatin GEMOX
Medical condition: Non Hodgkin s disease of lymphocyte T derivation
Disease: Version SOC Term Classification Code Term Level
6.1 10025321 HLGT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2004-001549-13 Sponsor Protocol Number: VAR102372 Start Date: 2004-09-14
Sponsor Name: GLAXO SMITHKLINE
Full Title: A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual...
Medical condition: ERECTILE DISFUNCTION
Disease: Version SOC Term Classification Code Term Level
6.1 10061461 PT
Population Age: Adults Gender: Male
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-003355-39 Sponsor Protocol Number: E2020-E044-318 Start Date: 2004-09-14
Sponsor Name: Eisai Limited
Full Title: A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia.
Medical condition: Dementia associated with Parkinson's disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2004-000156-16 Sponsor Protocol Number: A509 1043 Start Date: 2004-09-14
Sponsor Name: Pfizer AB
Full Title: Phase 3 multi center, double blind, randomized, parallel group evaluation of the fixed combination torcetrapib/atorvastatin, administered orally, once daily (QD), compared with atorvastatin alone, ...
Medical condition: Coronary Heart Disease
Disease: Version SOC Term Classification Code Term Level
10011078
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-000134-37 Sponsor Protocol Number: 20010184 Start Date: 2004-09-14
Sponsor Name: Amgen Inc.
Full Title: Trial to Reduce Cardiovascular Events with Aranesp Therapy
Medical condition: Treatment of anaemia in subjects with chronic kidney disease (CKD) amd Type 2 diabetes mellitus (DM)
Disease: Version SOC Term Classification Code Term Level
6.1 10038444 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) SK (Completed) CZ (Completed) LV (Completed) SE (Completed) IT (Completed) DK (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2004-001450-84 Sponsor Protocol Number: XM02-03-INT Start Date: 2004-09-14
Sponsor Name: BioGeneriX
Full Title: Safety and Efficacy of XM 02 in patients with small cell or non small cell lung cancer receiving platinum-based chemotherapy. Multinational, multicentre, randomised, controlled study
Medical condition: Patients with small cell or non small cell lung cancer receiving platinum-based chemotherapy and developing Neutropenia due to chemotherapy.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) LT (Completed)
Trial results: (No results available)
3